Bone Biologics Corp - BBLG

Detailed investor-level table based on 13F positions.

Shareholders (13F)

Quarter: Q3 2026 · Compare: Q2 2026
13D/13G major owners: Ownership tab.
Methodology: Market value and % of portfolio use SEC reported VALUE ($000). For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received. Details.
Rows: 0
Investor History Status Shares held Market value ($000) % of portfolio Previous % Rank Change in shares % change in shares Source Date reported
ARMISTICE CAPITAL, LLC History New 290,000 143 0.0% — 1 +290,000 New Q3 2026 Nov 16, 2026
HRT FINANCIAL LP History New 67,963 33 0.0% — 2 +67,963 New Q3 2026 Nov 13, 2026
CITADEL ADVISORS LLC History Added to 42,126 20 0.0% 0.0% 3 +18,247 76.41% Q3 2026 Nov 16, 2026
Virtu Financial LLC History New 20,694 10 0.0% — 4 +20,694 New Q3 2026 Nov 17, 2026
SUSQUEHANNA INTERNATIONAL GROUP, LLP History New 11,970 5 0.0% — 5 +11,970 New Q3 2026 Nov 16, 2026
Tower Research Capital LLC (TRC) History Added to 2,244 1 0.0% 0.0% 6 +291 14.9% Q3 2026 Nov 16, 2026
SBI Securities Co., Ltd. History Added to 341 0 — — — +111 48.26% Q3 2026 Oct 21, 2026
Caitong International Asset Management Co., Ltd History New 1 0 — — — +1 New Q3 2026 Oct 29, 2026